Singapore, March 10 -- Charles River Laboratories reinforced its commitment to strengthening the Asia Pacific biomanufacturing ecosystem by signing a series of strategic Memorandums of Understanding during the APAC Biomanufacturing Leadership Summit 2026.

The agreements were signed with NSG Bio, Locus Cell Co Ltd Taiwan, and Taiwan Bio Manufacturing Corporation, reflecting a shared ambition to expand collaboration across the region's rapidly growing biologics and advanced therapy landscape.

The partnerships are expected to support deeper engagement across the biologics development value chain, including research, manufacturing innovation, and technical collaboration. By aligning capabilities with regional biotechnology companies and man...